SkyWest (NASDAQ:SKYW – Free Report) had its price objective boosted by Raymond James from $100.00 to $114.00 in a research note issued to investors on Friday morning, Benzinga reports. Raymond James currently has an outperform rating on the transportation company’s stock.
SkyWest Stock Performance
NASDAQ:SKYW opened at $99.24 on Friday. The company has a debt-to-equity ratio of 0.95, a current ratio of 0.86 and a quick ratio of 0.74. The business has a fifty day simple moving average of $85.31 and a two-hundred day simple moving average of $80.20. SkyWest has a 1 year low of $41.96 and a 1 year high of $103.49. The company has a market capitalization of $3.98 billion, a P/E ratio of 16.96 and a beta of 1.93.
SkyWest (NASDAQ:SKYW – Get Free Report) last released its earnings results on Thursday, October 31st. The transportation company reported $2.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.92 by $0.24. The business had revenue of $912.79 million during the quarter, compared to the consensus estimate of $896.21 million. SkyWest had a return on equity of 11.02% and a net margin of 7.29%. The business’s revenue for the quarter was up 19.1% on a year-over-year basis. During the same period last year, the business posted $0.55 earnings per share. On average, analysts expect that SkyWest will post 6.96 earnings per share for the current year.
Institutional Investors Weigh In On SkyWest
SkyWest Company Profile
SkyWest, Inc is the holding company for two scheduled passenger airline operations and an aircraft leasing company. SkyWest’s airline companies provide commercial air service in cities throughout North America with nearly 3,000 daily flights carrying more than 53 million passengers annually. SkyWest Airlines operates through partnerships with United Airlines, Delta Air Lines, American Airlines and Alaska Airlines.
Read More
- Five stocks we like better than SkyWest
- How to Invest in Small Cap Stocks
- Intel: Is Now the Time to Be Brave?
- Trading Stocks: RSI and Why it’s Useful
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Business Services Stocks Investing
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for SkyWest Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SkyWest and related companies with MarketBeat.com's FREE daily email newsletter.